Conference abstractPublished 10 Jun 2019
Synthesis and cytotoxicity evaluation of novel amide and sulfonimide PPARa antagonists
University of Chieti, Italy
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Peroxisome Proliferator-Activated Receptors (PPARs) have been widely studied in the last decades, and they attracted the attention of scientists as promising therapeutic targets. Intensive efforts by researchers produced a wide panel of drugs targeting the three PPAR subtypes (PPAR, PPAR, PPAR) able to modulate important metabolic functions. PPAR activation is involved in several physiologic pathways, as lipid and glucose metabolism, insulin sensitivity, energy homeostasis, and cell differentiation. Fibrates and thiazolidinediones, respectively synthetic PPAR and PPAR agonists, are currently used for the treatment of hyperlipidemia and hyperglycemia, in patients affected by type 2 diabetes and metabolic syndrome. In recent years, an increased expression of PPAR has been found in different tumors: it is well known that cancer cells present altered metabolic pathways, switching from the glycolysis to fatty acid oxidation metabolism. In this scenario, PPAR antagonists emerged as novel potential drugs in tumors overexpressing PPAR, by interfering with cellular survival and metastasis formation [1]. In vitro anticancer effects were found for PPAR antagonists in chronic lymphocytic leukemia [2], renal cancer [3], colorectal and pancreatic cancer [4], paraganglioma [5]. In this study we report on the synthesis of novel amide and sulfonimide PPAR antagonists, starting from the structure of PPAR agonists, previously synthesized in our laboratory. Furthermore, we explored the possible cytotoxicity of the novel compounds in different cancer cell lines (colorectal, pancreatic and paraganglioma) expressing PPAR
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- BylineArticles whose byline prints “Alessandra Ammazzalorso”